Antibiotice Statistics
Total Valuation
Antibiotice has a market cap or net worth of RON 2.18 billion. The enterprise value is 2.23 billion.
Market Cap | 2.18B |
Enterprise Value | 2.23B |
Important Dates
The next estimated earnings date is Friday, November 15, 2024.
Earnings Date | Nov 15, 2024 |
Ex-Dividend Date | Sep 23, 2024 |
Share Statistics
Antibiotice has 671.34 million shares outstanding. The number of shares has increased by 0.03% in one year.
Shares Outstanding | 671.34M |
Shares Change (YoY) | +0.03% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.00% |
Owned by Institutions (%) | 0.16% |
Float | 117.94M |
Valuation Ratios
The trailing PE ratio is 23.32.
PE Ratio | 23.32 |
Forward PE | n/a |
PS Ratio | 3.34 |
PB Ratio | 2.51 |
P/FCF Ratio | 48.12 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.19, with an EV/FCF ratio of 49.40.
EV / Earnings | 23.94 |
EV / Sales | 3.43 |
EV / EBITDA | 16.19 |
EV / EBIT | 21.93 |
EV / FCF | 49.40 |
Financial Position
The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.14.
Current Ratio | 2.13 |
Quick Ratio | 1.37 |
Debt / Equity | 0.14 |
Debt / EBITDA | 0.86 |
Debt / FCF | 2.62 |
Interest Coverage | 25.38 |
Financial Efficiency
Return on equity (ROE) is 11.86% and return on invested capital (ROIC) is 7.17%.
Return on Equity (ROE) | 11.86% |
Return on Assets (ROA) | 5.74% |
Return on Capital (ROIC) | 7.17% |
Revenue Per Employee | 481,288 |
Profits Per Employee | 68,994 |
Employee Count | 1,352 |
Asset Turnover | 0.59 |
Inventory Turnover | 1.41 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +180.51% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +180.51% |
50-Day Moving Average | 2.99 |
200-Day Moving Average | 2.26 |
Relative Strength Index (RSI) | 60.40 |
Average Volume (20 Days) | 212,526 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Antibiotice had revenue of RON 650.70 million and earned 93.28 million in profits. Earnings per share was 0.14.
Revenue | 650.70M |
Gross Profit | 410.42M |
Operating Income | 101.81M |
Pretax Income | 97.38M |
Net Income | 93.28M |
EBITDA | 137.89M |
EBIT | 101.81M |
Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 60.75 million in cash and 118.43 million in debt, giving a net cash position of -57.68 million or -0.09 per share.
Cash & Cash Equivalents | 60.75M |
Total Debt | 118.43M |
Net Cash | -57.68M |
Net Cash Per Share | -0.09 |
Equity (Book Value) | 865.49M |
Book Value Per Share | 1.29 |
Working Capital | 272.11M |
Cash Flow
In the last 12 months, operating cash flow was 160.94 million and capital expenditures -115.74 million, giving a free cash flow of 45.20 million.
Operating Cash Flow | 160.94M |
Capital Expenditures | -115.74M |
Free Cash Flow | 45.20M |
FCF Per Share | 0.07 |
Margins
Gross margin is 63.07%, with operating and profit margins of 15.65% and 14.34%.
Gross Margin | 63.07% |
Operating Margin | 15.65% |
Pretax Margin | 14.97% |
Profit Margin | 14.34% |
EBITDA Margin | 21.19% |
EBIT Margin | 15.65% |
FCF Margin | 6.95% |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 2.51%.
Dividend Per Share | 0.08 |
Dividend Yield | 2.51% |
Dividend Growth (YoY) | 946.97% |
Years of Dividend Growth | 1 |
Payout Ratio | 3.94% |
Buyback Yield | -0.03% |
Shareholder Yield | 2.47% |
Earnings Yield | 4.29% |
FCF Yield | 2.08% |
Stock Splits
The last stock split was on May 13, 2013. It was a forward split with a ratio of 1.1819213313.
Last Split Date | May 13, 2013 |
Split Type | Forward |
Split Ratio | 1.1819213313 |
Scores
Antibiotice has an Altman Z-Score of 3.18.
Altman Z-Score | 3.18 |
Piotroski F-Score | n/a |